The ideal bio stent is a good product in still moving forward with its clinical trials. Wait a couple more years when they get approval to sell then the gloves come off. They are seeing improvements. Nothing's for sure but I'm going to wait it out. If anything that have is a big winner in the marketplace for Pharmaceuticals or Healthcare nothing I can say or do here will change the direction of this stock.
Market Data 
Markets 
AI
